{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:26:25Z","timestamp":1778019985576,"version":"3.51.4"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104051"],"award-info":[{"award-number":["82104051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH347 ZR2021QH094 ZR2021MH191"],"award-info":[{"award-number":["ZR2020QH347 ZR2021QH094 ZR2021MH191"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Hyperuricemic nephropathy (HN) is a common clinical complication of hyperuricemia. The pathogenesis of HN is directly related to urea metabolism in the gut microbiota. Febuxostat, a potent xanthine oxidase inhibitor, is the first-line drug used for the treatment of hyperuricemia. However, there have been few studies on the pharmacokinetics of febuxostat in HN animal models or in patients. In this study, a high-purine diet-induced HN rat model was established. The pharmacokinetics of febuxostat in HN rats was evaluated using LC-MS\/MS. Astragaloside IV (AST) was used to correct the abnormal pharmacokinetics of febuxostat. Gut microbiota diversity analysis was used to evaluate the effect of AST on gut microbiota. The results showed that the delayed elimination of febuxostat caused drug accumulation after multiple administrations. Oral but not i. p. AST improved the pharmacokinetics of febuxostat in HN rats. The mechanistic study showed that AST could regulate urea metabolism in faeces and attenuate urea-ammonia liver-intestine circulation. Urease-related genera, including <jats:italic>Eubacterium<\/jats:italic>, <jats:italic>Parabacteroides<\/jats:italic>, <jats:italic>Ruminococcus<\/jats:italic>, and <jats:italic>Clostridia<\/jats:italic>, decreased after AST prevention. In addition, the decrease in pathogenic genera and increase in short-chain fatty acids (SCFA) producing genera also contribute to renal function recovery. In summary, AST improved the pharmacokinetics of febuxostat in HN rats by comprehensive regulation of the gut microbiota, including urea metabolism, anti-calcification, and short-chain fatty acid generation. These results imply that febuxostat might accumulate in HN patients, and AST could reverse the accumulation through gut microbiota regulation.<\/jats:p>","DOI":"10.3389\/fphar.2022.1031509","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T05:05:01Z","timestamp":1671512701000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Astragaloside IV improves the pharmacokinetics of febuxostat in rats with hyperuricemic nephropathy by regulating urea metabolism in gut microbiota"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhen Xiong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Hui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng Lu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia Qian","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan Dan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/mnh.0000000000000619","article-title":"The role of uric acid in inflammasome-mediated kidney injury","volume":"29","author":"Braga","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B2","first-page":"5029","article-title":"Astragaloside IV attenuates renal fibrosis through repressing epithelial-to-mesenchymal transition by inhibiting microRNA-192 expression: In vivo and in vitro studies","volume":"11","author":"Cao","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"837205","DOI":"10.3389\/fcimb.2022.837205","article-title":"FuZhengHuaYuJiangZhuTongLuoFang prescription modulates gut microbiota and gut-derived metabolites in UUO rats","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/s0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.2147\/dddt.s171286","article-title":"Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-\u03b21\/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy","volume":"12","author":"Du","year":"2018","journal-title":"Drug Des. devel. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1128\/iai.65.6.2313-2320.1997","article-title":"Clostridium perfringens urease genes are plasmid borne","volume":"65","author":"Dupuy","year":"1997","journal-title":"Infect. Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.semnephrol.2020.12.004","article-title":"Hyperuricemia in kidney disease: A major risk factor for cardiovascular events, vascular calcification, and renal damage","volume":"40","author":"Ejaz","year":"2020","journal-title":"Semin. Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"732503","DOI":"10.3389\/fphar.2021.732503","article-title":"Model based identification of linezolid exposure-toxicity thresholds in hospitalized patients","volume":"12","author":"Fang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrurol.2014.99","article-title":"Renal struvite stones--pathogenesis, microbiology, and management strategies","volume":"11","author":"Flannigan","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"610102","DOI":"10.3389\/fphar.2020.610102","article-title":"Astragaloside IV alleviates tacrolimus-induced chronic nephrotoxicity via p62-keap1-nrf2 pathway","volume":"11","author":"Gao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1159\/000515419","article-title":"The kidney-heart connection in obesity","volume":"145","author":"Garc\u00eda-Carrasco","year":"2021","journal-title":"Nephron"},{"key":"B12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1742-7843.2004.t01-1-pto950508.x","article-title":"Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali","volume":"95","author":"Gu","year":"2004","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1096\/fj.201902597RR","article-title":"Protective effects of tuna meat oligopeptides (TMOP) supplementation on hyperuricemia and associated renal inflammation mediated by gut microbiota","volume":"34","author":"Han","year":"2020","journal-title":"Faseb J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","article-title":"Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: Report of a scientific workshop organized by the national kidney foundation","volume":"71","author":"Johnson","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1574-695X.1993.tb00384.x","article-title":"Analysis of intestinal flora of a patient with congenital absence of the portal vein","volume":"7","author":"Kamiya","year":"1993","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1042\/cs20160203","article-title":"Urea, a true uremic toxin: The empire strikes back","volume":"131","author":"Lau","year":"2017","journal-title":"Clin. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/jat.3603","article-title":"Alteration of renal excretion pathways in gentamicin-induced renal injury in rats","volume":"38","author":"Ma","year":"2018","journal-title":"J. Appl. Toxicol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/jcm7100315","article-title":"Supplementation of short-chain fatty acid, sodium propionate, in patients on maintenance hemodialysis: Beneficial effects on inflammatory parameters and gut-derived uremic toxins, A pilot study (plan study)","volume":"7","author":"Marzocco","year":"2018","journal-title":"J. Clin. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.apsb.2019.10.007","article-title":"Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia","volume":"10","author":"Pan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"B20","doi-asserted-by":"publisher","first-page":"812594","DOI":"10.3389\/fphar.2022.812594","article-title":"Therapeutic potential of astragaloside IV against adriamycin-induced renal damage in rats via ferroptosis","volume":"13","author":"Qin","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ekir.2020.10.034","article-title":"Encrusted urinary tract infections due to corynebacteria species","volume":"6","author":"Sakhi","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0155620","DOI":"10.1371\/journal.pone.0155620","article-title":"Dietary regulation of the gut microbiota engineered by a minimal defined bacterial consortium","volume":"11","author":"Shen","year":"2016","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41584-021-00657-4","article-title":"Management of gout in chronic kidney disease: A G-CAN consensus statement on the research priorities","volume":"17","author":"Stamp","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/hep.29915","article-title":"Disruption of renal arginine metabolism promotes kidney injury in hepatorenal syndrome in mice","volume":"68","author":"Varga","year":"2018","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.3892\/etm.2019.7495","article-title":"Astragaloside IV ameliorates high glucose-induced HK-2 cell apoptosis and oxidative stress by regulating the Nrf2\/ARE signaling pathway","volume":"17","author":"Wang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"BSR20190987","DOI":"10.1042\/bsr20190987","article-title":"Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-\u03b2\/Smad pathway in renal proximal tubular epithelial cells","volume":"40","author":"Wang","year":"2020","journal-title":"Biosci. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41392-020-00456-5","article-title":"Oral berberine improves brain dopa\/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.51893\/2020.2.oa6","article-title":"Continuous renal replacement therapy and its impact on hyperammonaemia in acute liver failure","volume":"22","author":"Warrillow","year":"2020","journal-title":"Crit. Care Resusc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1111\/1462-2920.12217","article-title":"Complete genome of a new Firmicutes species belonging to the dominant human colonic microbiota ('Ruminococcus bicirculans') reveals two chromosomes and a selective capacity to utilize plant glucans","volume":"16","author":"Wegmann","year":"2014","journal-title":"Environ. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"112404","DOI":"10.1016\/j.jep.2019.112404","article-title":"Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-\u03b2\/Smads pathway","volume":"249","author":"Wei","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s11010-020-03997-z","article-title":"The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy","volume":"476","author":"Wen","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1073\/pnas.0812874106","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites","volume":"106","author":"Wikoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"636154","DOI":"10.3389\/fphar.2021.636154","article-title":"Pharmacologic targeting of BET proteins attenuates hyperuricemic nephropathy in rats","volume":"12","author":"Xiong","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/0886022x.2019.1633350","article-title":"The role of oxidative stress-mediated apoptosis in the pathogenesis of uric acid nephropathy","volume":"41","author":"Yang","year":"2019","journal-title":"Ren. Fail."},{"key":"B36","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.7150\/thno.28068","article-title":"Gut-brain axis metabolic pathway regulates antidepressant efficacy of albiflorin","volume":"8","author":"Zhao","year":"2018","journal-title":"Theranostics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e2004529","DOI":"10.1002\/adma.202004529","article-title":"Prebiotics-encapsulated probiotic spores regulate gut microbiota and suppress colon cancer","volume":"32","author":"Zheng","year":"2020","journal-title":"Adv. Mat."},{"key":"B38","doi-asserted-by":"publisher","first-page":"105192","DOI":"10.1016\/j.phrs.2020.105192","article-title":"Renal protective effects of astragaloside IV, in diabetes mellitus kidney damage animal models: A systematic review, meta-analysis","volume":"160","author":"Zhou","year":"2020","journal-title":"Pharmacol. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1031509\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T05:05:06Z","timestamp":1671512706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1031509\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":38,"alternative-id":["10.3389\/fphar.2022.1031509"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1031509","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"article-number":"1031509"}}